
10,000+ employees
Founded 1962
🏭 Manufacturing
🍽️ Food & Beverage
💼 Consulting
Manufacturing • Food & Beverage • Consulting
Pierre Fabre Group is a worldwide company held by the Pierre Fabre Foundation, uniquely positioned at the intersection of pharmaceuticals and dermocosmetics. As the second largest dermo-cosmetics laboratory in the world and a notable player in the pharmaceutical sector, Pierre Fabre Group offers a wide array of health and beauty products including oncology, skincare, and personal care solutions. With over 9,600 employees across 44 subsidiaries and operations in 120 countries, the company generates significant international revenues, emphasizing its commitment to innovation and sustainability in its manufacturing processes, primarily based in France.
Selected: 🆕 Date Added.
🔥 7 hours ago
Cellular therapy account director launching Pierre Fabre’s Tab-cel treatment for rare transplant-related lymphoma. Managing major US treatment-center accounts across the Northwest.
🏄 California, Idaho, +4 more states – Remote
💵 $170k - $250k / year
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 0%
🔥 7 hours ago
Cellular therapy account director launching Pierre Fabre’s rare-disease oncology treatment across the Southwest. Driving Tab-cel adoption, treatment-center onboarding, and strategic account plans.
🌵 Arizona, California, +1 more states – Remote
💵 $170k - $250k / year
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 0%
🔥 7 hours ago
Cellular therapy account director launching Pierre Fabre’s Tab-cel therapy for rare transplant-associated lymphoma. Managing institutional accounts and treatment-center adoption across the US Plains territory.
🇺🇸 United States – Remote
💵 $170k - $250k / year
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 0%
🔥 7 hours ago
Cellular therapy account director launching Pierre Fabre’s Tab-cel treatment for rare EBV+ PTLD. Managing transplant-center accounts and stakeholder relationships across a large US territory.
🌽 Illinois, Kentucky, +3 more states – Remote
💵 $170k - $250k / year
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 0%
🔥 7 hours ago
Cellular therapy account director launching Pierre Fabre’s rare-disease oncology treatment across the South Central US. Driving disease awareness, treatment-center onboarding, and Tab-cel adoption.
🏈 Alabama, Kansas, +3 more states – Remote
💵 $170k - $250k / year
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 0%
🔥 7 hours ago
Cellular therapy account director launching Pierre Fabre’s rare-disease oncology treatment across the Southeast. Building treatment-center relationships and driving Tab-cel access, adoption, and patient support.
🐊 Florida, North Carolina, +2 more states – Remote
💵 $170k - $250k / year
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 0%
🔥 7 hours ago
Cellular therapy account director launching Pierre Fabre’s Tab-cel treatment for rare transplant-related lymphoma. Managing US treatment-center relationships, onboarding, education, and account strategy.
🇺🇸 United States – Remote
💵 $170k - $250k / year
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 0%
🔥 7 hours ago
Cellular therapy account director launching Pierre Fabre’s Tab-cel treatment for rare EBV+ PTLD. Managing Northeast academic and transplant-center relationships, onboarding, and utilization.
🦌 Connecticut, Maine, +5 more states – Remote
💵 $170k - $250k / year
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 0%
🔥 7 hours ago
Field Medical Affairs leader supporting oncology stakeholders and clinical studies across the western United States. Building KOL relationships and executing regional medical strategy for Pierre Fabre Pharmaceuticals.
🌵 Arizona, California, +8 more states – Remote
💵 $170k - $250k / year
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 0%
🔥 7 hours ago
Field Medical Director supporting Pierre Fabre Pharmaceuticals’ oncology portfolio through KOL engagement, clinical studies, and regional medical strategy. Remote, field-based Midwest role.
🔥 7 hours ago
National Access Director preparing payer coverage and reimbursement access for Pierre Fabre’s investigational Tab-cel cell therapy. Supporting treatment centers and financial stakeholders through US launch.
🕒 August 25
National account-management executive leading Pierre Fabre Pharma’s US commercial launch of allogeneic cell therapy. Driving sales, site activation, patient access, and high-performing account teams.